TF and breast carcinoma: This blockade of TF signaling resulted in decreased levels of epithelial-to-mesenchymal transition, reduced cancer stemness, and a decrease in the expression of pro-metastatic markers, namely Slug and SOX9, across multiple breast cancer cell lines [10].